This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David E. Schuller, MD

Arch Otolaryngol Head Neck Surg. 1991;117(5):498-501.

Abstract
• We provide an update on the current status of chemotherapy in the treatment of head and neck cancer. The role of the otolaryngology—head and neck surgeon in this important clinical research is underscored. Those involved with treating patients with head and neck cancer must understand the mechanisms of clinical cancer research. Physicians in academic and community settings can be intimately involved in this treatment.

(Arch Otolaryngol Head Neck Surg. 1991;117:498-501)

Author Affiliations
From the Comprehensive Cancer Center Head and Neck Oncology Program and the Department of Otolaryngology, The Ohio State University, Columbus.

Footnotes
Accepted for publication December 27, 1990.

Reprint requests to Department of Otolaryngology, The Ohio State University, 456 Clinic Dr, Columbus, OH 43210 (Dr Schuller).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multimodal Intensification Regimens for Advanced, Resectable, Previously Untreated Squamous Cell Cancer of the Oral Cavity, Oropharynx, or Hypopharynx: A 12-Year Experience
Schuller et al.
Arch Otolaryngol Head Neck Surg 2007;133:320-326.
ABSTRACT | FULL TEXT  

Intensified Regimen for Advanced Head and Neck Squamous Cell Carcinomas
Schuller et al.
Arch Otolaryngol Head Neck Surg 1997;123:139-144.
ABSTRACT